RENAL CELL CANCER
Clinical trials for RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer vaccine Modi-1 enters human trials for four tumor types
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called Modi-1, designed to train the immune system to attack cancer cells. It is given as a tiny shot into the skin using a special microneedle device. The trial includes 168 people with advanced triple-negative breast cancer, head and neck cancer, …
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Scancell Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 18:32 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment for adults with certain cancers (pancreatic, kidney, breast, melanoma, or ovarian) that have a protein called CD70. Doctors take a sample of your blood, modify your white blood cells in a lab to recognize and attack CD70, and then give them back t…
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called JNJ-87890387 in people with advanced solid tumors that have spread or cannot be removed. The drug is designed to help the immune system attack cancer cells. The main goals are to find a safe dose and to check for side effects. About …
Matched conditions: RENAL CELL CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill-and-immunotherapy cocktail takes on advanced tumors
Disease control Recruiting nowThis study tests an experimental oral drug called Alintegimod (7HP349) combined with two standard immunotherapies (ipilimumab and nivolumab) in people with advanced solid tumors like melanoma, lung, kidney, and liver cancers. The trial has two parts: first, finding a safe dose (p…
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental combo aims to reboot immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing an anti-PD-1 antibody (a type of immunotherapy) alone or combined with low-dose decitabine and/or standard chemotherapy in people whose cancers have come back or not responded to treatment. The trial includes patients with several cancer types, such as lymph…
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Han weidong • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…
Matched conditions: RENAL CELL CANCER
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New study tests kidney cancer combo in patients over 70
Disease control Recruiting nowThis study is looking at how older patients (70 years and older) with advanced kidney cancer handle a combination of two drugs: cabozantinib (a daily pill) and nivolumab (an IV infusion). The goal is to see how doctors actually use these drugs in real life, including starting dos…
Matched conditions: RENAL CELL CANCER
Phase: PHASE4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New ultrasound tech may predict kidney function after surgery
Knowledge-focused Recruiting nowThis study is testing whether two advanced ultrasound techniques—contrast-enhanced ultrasound and super-resolution imaging—can predict how well a person's kidneys will recover after surgery for kidney cancer. Researchers will scan the kidneys before and after surgery and track ki…
Matched conditions: RENAL CELL CANCER
Sponsor: Jinling Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC